Leonard T M, Klem S A, Asher M A, Rapoff M A, Leff R D
Department of Pharmacy, University of Kansas Medical Center, Kansas City 66160.
Pharmacotherapy. 1993 Jul-Aug;13(4):378-81.
To examine the relationship among postoperative pain severity, serum beta-endorphin level, and serum morphine level in pediatric patients after posterior spinal fusion with instrumentation.
A prospective study.
University-based medical center.
Ten patients age 13-17 years admitted for posterior spinal fusion with instrumentation.
Each subject was administered an initial dose of intravenous morphine 100 micrograms/kg, followed by a constant infusion of 50 micrograms/kg/hour. The primary physician was allowed to titrate the dosage as required to meet the patient's requirement for analgesia. Whole blood was obtained for the analysis of serum morphine and beta-endorphin levels preoperatively, after the initial morphine dose, 24 hours after initiation of the infusion, and before any change in dosage. At each blood sampling time, pain severity ratings were obtained from the subject, nurse, and parent using a 10-point linear scale.
No statistical difference between serum beta-endorphin values preoperatively and after the initial dose of morphine was observed; mean values were 68 and 60 pg/ml, respectively. The relationships between serum beta-endorphin level and pain scores were statistically significant only for self (subject) pain scores (p = 0.014, r = 0.30). Mean serum morphine level was 21.9 ng/ml for patients with self pain scores of 4 or less.
The clinical usefulness of serum beta-endorphin as a measure of pain severity was not established under the experimental conditions of this study.
探讨小儿后路脊柱融合内固定术后疼痛严重程度、血清β-内啡肽水平和血清吗啡水平之间的关系。
前瞻性研究。
大学附属医院。
10例年龄在13 - 17岁接受后路脊柱融合内固定术的患者。
每位受试者静脉注射初始剂量为100微克/千克的吗啡,随后以50微克/千克/小时的速度持续输注。主治医生可根据需要调整剂量以满足患者的镇痛需求。术前、初始吗啡剂量后、输注开始24小时后以及剂量改变前采集全血,用于分析血清吗啡和β-内啡肽水平。在每次采血时,使用10分线性量表从受试者、护士和家长处获取疼痛严重程度评分。
术前与初始吗啡剂量后血清β-内啡肽值无统计学差异;平均值分别为68和60皮克/毫升。血清β-内啡肽水平与疼痛评分之间的关系仅在自我(受试者)疼痛评分方面具有统计学意义(p = 0.014,r = 0.30)。自我疼痛评分为4分及以下的患者血清吗啡平均水平为21.9纳克/毫升。
在本研究的实验条件下,血清β-内啡肽作为疼痛严重程度指标的临床实用性未得到证实。